Relay Therapeutics rakes in $57 mln Series A

Cambridge, Massachusetts-based Relay Therapeutics, a newly launched company focused on "building the first dedicated drug discovery pipeline centered on protein motion," has raised $57 million in Series A financing. The investors are Third Rock Ventures and D. E. Shaw Research LLC.

North AmericaUSBriefs